167 related articles for article (PubMed ID: 30897170)
1. Adapalene-loaded poly(ε-caprolactone) microparticles: Physicochemical characterization and in vitro penetration by photoacoustic spectroscopy.
Nadal JM; Dos Anjos Camargo G; Novatski A; Macenhan WR; Dias DT; Barboza FM; Lyra A; Roik JR; Padilha de Paula J; Somer A; Farago PV
PLoS One; 2019; 14(3):e0213625. PubMed ID: 30897170
[TBL] [Abstract][Full Text] [Related]
2. Microencapsulation of cytarabine using poly(ethylene glycol)-poly(epsilon-caprolactone) diblock copolymers as surfactant agents.
Diab R; Hamoudeh M; Boyron O; Elaissari A; Fessi H
Drug Dev Ind Pharm; 2010 Apr; 36(4):456-69. PubMed ID: 19877831
[TBL] [Abstract][Full Text] [Related]
3. Synthesis, characterizations, in vitro and in vivo evaluation of Etoricoxib-loaded Poly (Caprolactone) microparticles--a potential Intra-articular drug delivery system for the treatment of Osteoarthritis.
Arunkumar P; Indulekha S; Vijayalakshmi S; Srivastava R
J Biomater Sci Polym Ed; 2016; 27(4):303-16. PubMed ID: 26689653
[TBL] [Abstract][Full Text] [Related]
4. Enhanced gastric tolerability and improved anti-obesity effect of capsaicinoids-loaded PCL microparticles.
Almeida MA; Nadal JM; Grassiolli S; Paludo KS; Zawadzki SF; Cruz L; Paula JP; Farago PV
Mater Sci Eng C Mater Biol Appl; 2014 Jul; 40():345-56. PubMed ID: 24857502
[TBL] [Abstract][Full Text] [Related]
5. PHBV/PCL microparticles for controlled release of resveratrol: physicochemical characterization, antioxidant potential, and effect on hemolysis of human erythrocytes.
Mendes JB; Riekes MK; de Oliveira VM; Michel MD; Stulzer HK; Khalil NM; Zawadzki SF; Mainardes RM; Farago PV
ScientificWorldJournal; 2012; 2012():542937. PubMed ID: 22666135
[TBL] [Abstract][Full Text] [Related]
6. The preparation and evaluation of poly(epsilon-caprolactone) microparticles containing both a lipophilic and a hydrophilic drug.
Hombreiro Pérez M; Zinutti C; Lamprecht A; Ubrich N; Astier A; Hoffman M; Bodmeier R; Maincent P
J Control Release; 2000 Apr; 65(3):429-38. PubMed ID: 10699300
[TBL] [Abstract][Full Text] [Related]
7. Effects of crystalline microstructure on drug release behavior of poly(epsilon-caprolactone) microspheres.
Jeong JC; Lee J; Cho K
J Control Release; 2003 Oct; 92(3):249-58. PubMed ID: 14568406
[TBL] [Abstract][Full Text] [Related]
8. Preparation and characterization of starch-poly-epsilon-caprolactone microparticles incorporating bioactive agents for drug delivery and tissue engineering applications.
Balmayor ER; Tuzlakoglu K; Azevedo HS; Reis RL
Acta Biomater; 2009 May; 5(4):1035-45. PubMed ID: 19095509
[TBL] [Abstract][Full Text] [Related]
9. Full factorial design optimization of anti-inflammatory drug release by PCL-PEG-PCL microspheres.
Azouz L; Dahmoune F; Rezgui F; G'Sell C
Mater Sci Eng C Mater Biol Appl; 2016 Jan; 58():412-9. PubMed ID: 26478328
[TBL] [Abstract][Full Text] [Related]
10. PCL/PHBV microparticles as innovative carriers for oral controlled release of manidipine dihydrochloride.
Barboza FM; Machado WM; Olchanheski Junior LR; Padilha de Paula J; Zawadzki SF; Fernandes D; Farago PV
ScientificWorldJournal; 2014; 2014():268107. PubMed ID: 24550699
[TBL] [Abstract][Full Text] [Related]
11. Intradermal and follicular delivery of adapalene liposomes.
Kumar V; Banga AK
Drug Dev Ind Pharm; 2016; 42(6):871-9. PubMed ID: 27031916
[TBL] [Abstract][Full Text] [Related]
12. The effect of formulation variables on the characteristics of insulin-loaded poly(lactic-co-glycolic acid) microspheres prepared by a single phase oil in oil solvent evaporation method.
Hamishehkar H; Emami J; Najafabadi AR; Gilani K; Minaiyan M; Mahdavi H; Nokhodchi A
Colloids Surf B Biointerfaces; 2009 Nov; 74(1):340-9. PubMed ID: 19717287
[TBL] [Abstract][Full Text] [Related]
13. Microparticles prepared with poly(hydroxybutyrate-co-hydroxyvalerate) and poly(epsilon-caprolactone) blends to control the release of a drug model.
Lionzo MI; Ré MI; Guterres SS; Pohlmann AR
J Microencapsul; 2007 Mar; 24(2):175-86. PubMed ID: 17454428
[TBL] [Abstract][Full Text] [Related]
14. Influence of polymer blends on the characterization of gliclazide--encapsulated into poly (ε-caprolactone) microparticles.
Barakat NS; Shazly GA; Almedany AH
Drug Dev Ind Pharm; 2013 Feb; 39(2):352-62. PubMed ID: 22540378
[TBL] [Abstract][Full Text] [Related]
15. Preliminary investigation on the design of biodegradable microparticles for ivermectin delivery: set up of formulation parameters.
Dorati R; Genta I; Colzani B; Tripodo G; Conti B
Drug Dev Ind Pharm; 2015; 41(7):1182-92. PubMed ID: 24994001
[TBL] [Abstract][Full Text] [Related]
16. Sustained antibacterial activity of doxycycline-loaded poly(D,L-lactide-co-glycolide) and poly(epsilon-caprolactone) nanoparticles.
Misra R; Acharya S; Dilnawaz F; Sahoo SK
Nanomedicine (Lond); 2009 Jul; 4(5):519-30. PubMed ID: 19572818
[TBL] [Abstract][Full Text] [Related]
17. Engineering of poly(epsilon-caprolactone) microcarriers to modulate protein encapsulation capability and release kinetic.
Coccoli V; Luciani A; Orsi S; Guarino V; Causa F; Netti PA
J Mater Sci Mater Med; 2008 Apr; 19(4):1703-11. PubMed ID: 17914622
[TBL] [Abstract][Full Text] [Related]
18. Oridonin-loaded poly(epsilon-caprolactone)-poly(ethylene oxide)-poly(epsilon-caprolactone) copolymer nanoparticles: preparation, characterization, and antitumor activity on mice with transplanted hepatoma.
Feng N; Wu P; Li Q; Mei Y; Shi S; Yu J; Xu J; Liu Y; Wang Y
J Drug Target; 2008 Jul; 16(6):479-85. PubMed ID: 18604660
[TBL] [Abstract][Full Text] [Related]
19. Long-lasting anti-platelet activity of cilostazol from poly(ε-caprolactone)-poly(ethylene glycol) blend nanocapsules.
Gomes MLS; da Silva Nascimento N; Borsato DM; Pretes AP; Nadal JM; Novatski A; Gomes RZ; Fernandes D; Farago PV; Zanin SMW
Mater Sci Eng C Mater Biol Appl; 2019 Jan; 94():694-702. PubMed ID: 30423756
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of drug delivery characteristics of microspheres of PMMA-PCL-cholesterol obtained by supercritical-CO2 impregnation and by dissolution-evaporation techniques.
Elvira C; Fanovich A; Fernández M; Fraile J; San Román J; Domingo C
J Control Release; 2004 Sep; 99(2):231-40. PubMed ID: 15380633
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
